Pancreatic Cancer News and Research

RSS
Pancreatic cancer is the fourth leading cause of all cancer deaths in the United States and the third leading cause of cancer deaths in individuals ages 40 to 60. Approximately 37,000 Americans are diagnosed with pancreatic cancer each year, and, each year, approximately the same number die from it. Often, pancreatic cancer is found too late for surgical intervention, and chemotherapy and radiation treatments have little effect.
Frequent consumption of nuts may reduce risk of breast, colon, pancreatic and lung cancer

Frequent consumption of nuts may reduce risk of breast, colon, pancreatic and lung cancer

MabVax receives FDA authorization to initiate 89Zr-HuMab-5B1 Phase I trial in pancreatic cancer patients

MabVax receives FDA authorization to initiate 89Zr-HuMab-5B1 Phase I trial in pancreatic cancer patients

Overall EU cancer, leukaemia mortality rates to fall in 2016

Overall EU cancer, leukaemia mortality rates to fall in 2016

Newly drafted consensus statement promotes widespread use of HPV vaccines to prevent cancer

Newly drafted consensus statement promotes widespread use of HPV vaccines to prevent cancer

Halozyme closes $150 million royalty-backed debt transaction

Halozyme closes $150 million royalty-backed debt transaction

ROCA Test now available in nine additional U.S. states for early detection of ovarian cancer

ROCA Test now available in nine additional U.S. states for early detection of ovarian cancer

UT Southwestern researchers reveal how CDK4/6-inhibitors alter pancreatic cancer cell metabolism

UT Southwestern researchers reveal how CDK4/6-inhibitors alter pancreatic cancer cell metabolism

AbbVie doses first subject in adalimumab clinical trial using Halozyme's ENHANZE technology

AbbVie doses first subject in adalimumab clinical trial using Halozyme's ENHANZE technology

Diabetes drug fails to show any benefit against pancreatic cancer

Diabetes drug fails to show any benefit against pancreatic cancer

Combining nanomedicine with two anticancer treatments could improve outcomes for pancreatic cancer patients

Combining nanomedicine with two anticancer treatments could improve outcomes for pancreatic cancer patients

Only 3% of GPs fully confident and informed about pancreatic cancer symptoms

Only 3% of GPs fully confident and informed about pancreatic cancer symptoms

WASF3 protein appears to be solid target for reducing cancer metastasis

WASF3 protein appears to be solid target for reducing cancer metastasis

First patients treated in Phase 1b trial of pembrolizumab with REOLYSIN in advanced pancreatic adenocarcinoma

First patients treated in Phase 1b trial of pembrolizumab with REOLYSIN in advanced pancreatic adenocarcinoma

MGH researchers find how metformin drug prevents progression of pancreatic cancer

MGH researchers find how metformin drug prevents progression of pancreatic cancer

LabCorp to offer Interpace's new ThyraMir microRNA classifier test

LabCorp to offer Interpace's new ThyraMir microRNA classifier test

New strategy may reduce growth of pancreatic cancers in patients with KRAS gene mutation

New strategy may reduce growth of pancreatic cancers in patients with KRAS gene mutation

CTCA at Western announces launch of Phase II NivoPlus clinical trial

CTCA at Western announces launch of Phase II NivoPlus clinical trial

Pancreatic cancer to surpass breast cancer to become third leading cause of deaths in U.S.

Pancreatic cancer to surpass breast cancer to become third leading cause of deaths in U.S.

Radiation therapy lowers risk of cancer recurrence in pancreatic cancer surgery patients

Radiation therapy lowers risk of cancer recurrence in pancreatic cancer surgery patients

Disease burden, health care costs higher in children with recurrent acute and chronic pancreatitis

Disease burden, health care costs higher in children with recurrent acute and chronic pancreatitis

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.